arrow
X

Xabier Agirre

CIMA Universidad de Navarra
H指数:61
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities

髓系休眠代谢转录组识别出高危预后亚组在超二倍体多发性骨髓瘤中具有可靶向的脆弱性

2026-08-110
OA
Stromal and endothelial transcriptional changes during progression from MGUS to myeloma and after treatment response

MGUS进展为骨髓瘤以及治疗后反应期间基质和内皮的转录变化

2026-06-230
OAAI
Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma

重编程谷氨酰胺代谢增强了BCMA-CART细胞的适应性和在多发性骨髓瘤中的治疗效能。

Blood
IF23.1
2025-09-220
OAAI
Mapping Disease Transitions from Premalignant, Asymptomatic to Advanced Myeloma through Integrative Epigenomic and Transcriptional Analyses

通过整合表观基因组学和转录组学分析,映射从癌前、无症状到晚期骨髓瘤的疾病转变。

BLOOD
IF23.1
2024-11-050
PRE
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1
2024-11-021
OAAI
BET inhibitors downregulate the expression of the essentiallncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1
2024-09-260
OAAI
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
2024-07-022
OAAI
An atlas of cells in the human tonsil
IMMUNITY
IF26.3
2024-02-0113
OAAI
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer

靶向组蛋白乙酰化调控膀胱癌肿瘤微环境的研究

2024-01-043
OAAI
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

用于预测遗传异质性多发性骨髓瘤的免疫治疗结果和免疫逃避机制的临床前模型

2023-03-1628
OAAI
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
2022-11-245
OAAI
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models

CM-272抑制G9a: 使用2D和3D体外模型开发去势抵抗性前列腺癌的新型抗肿瘤策略

2022-06-0112
OAAI